Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy

Arief Kartasasmita,1 Ohisa Harley2 1Departement of Ophthalmology, Universitas Padjadjaran/Cicendo Eye Hospital, Bandung, Indonesia; 2Netra Eye Hospital, Bandung, IndonesiaCorrespondence: Arief KartasasmitaDepartment of Ophthalmology, Universitas Padjadjaran, Jl. Cicendo No 4, Bandung 40141, Indonesi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kartasasmita A, Harley O
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	diabetic retinopathy diabetic macular edema bevacizumab panretinalphotocoagulation Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/86b4e74ee0884137b2b915bf5d963f82
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:86b4e74ee0884137b2b915bf5d963f82
record_format	dspace
spelling	oai:doaj.org-article:86b4e74ee0884137b2b915bf5d963f822021-12-02T03:21:33ZEvaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy1177-5483https://doaj.org/article/86b4e74ee0884137b2b915bf5d963f822019-09-01T00:00:00Zhttps://www.dovepress.com/evaluation-of-the-timing-of-intravitreal-bevacizumab-injection-as-adju-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Arief Kartasasmita,1 Ohisa Harley2 1Departement of Ophthalmology, Universitas Padjadjaran/Cicendo Eye Hospital, Bandung, Indonesia; 2Netra Eye Hospital, Bandung, IndonesiaCorrespondence: Arief KartasasmitaDepartment of Ophthalmology, Universitas Padjadjaran, Jl. Cicendo No 4, Bandung 40141, IndonesiaTel +62 22 4231280Email a.kartasasmita@unpad.ac.idObjective: To evaluate the difference in intravitreal bevacizumab (IVB) injection timing as adjuvant therapy to panretinal photocoagulation in patients with diabetic retinopathy combined with diabetic macular edema.Methods: This was a retrospective nonrandomized study. Forty eyes with severe non-proliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR) were divided into two groups; the IVB injection prior to, or after, panretinal photocoagulation. Changes in central macular thickness between the two groups were measured.Results: There was no significant difference in change in central macular thickness between two groups after treatment (p=0.66), neither in eyes with severe NPDR groups (p=0.48) nor eyes with PDR (p=0.82).Conclusion: IVB injection after panretinal photocoagulation gives insignificant difference in changes in central macular thickness with injection prior to laser treatment in patients with diabetic retinopathy combined with diabetic macular edema.Keywords: diabetic retinopathy, diabetic macular edema, bevacizumab, panretinal photocoagulationKartasasmita AHarley ODove Medical Pressarticlediabetic retinopathydiabetic macular edemabevacizumabpanretinalphotocoagulationOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 1921-1926 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	diabetic retinopathy diabetic macular edema bevacizumab panretinalphotocoagulation Ophthalmology RE1-994
spellingShingle	diabetic retinopathy diabetic macular edema bevacizumab panretinalphotocoagulation Ophthalmology RE1-994 Kartasasmita A Harley O Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
description	Arief Kartasasmita,1 Ohisa Harley2 1Departement of Ophthalmology, Universitas Padjadjaran/Cicendo Eye Hospital, Bandung, Indonesia; 2Netra Eye Hospital, Bandung, IndonesiaCorrespondence: Arief KartasasmitaDepartment of Ophthalmology, Universitas Padjadjaran, Jl. Cicendo No 4, Bandung 40141, IndonesiaTel +62 22 4231280Email a.kartasasmita@unpad.ac.idObjective: To evaluate the difference in intravitreal bevacizumab (IVB) injection timing as adjuvant therapy to panretinal photocoagulation in patients with diabetic retinopathy combined with diabetic macular edema.Methods: This was a retrospective nonrandomized study. Forty eyes with severe non-proliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR) were divided into two groups; the IVB injection prior to, or after, panretinal photocoagulation. Changes in central macular thickness between the two groups were measured.Results: There was no significant difference in change in central macular thickness between two groups after treatment (p=0.66), neither in eyes with severe NPDR groups (p=0.48) nor eyes with PDR (p=0.82).Conclusion: IVB injection after panretinal photocoagulation gives insignificant difference in changes in central macular thickness with injection prior to laser treatment in patients with diabetic retinopathy combined with diabetic macular edema.Keywords: diabetic retinopathy, diabetic macular edema, bevacizumab, panretinal photocoagulation
format	article
author	Kartasasmita A Harley O
author_facet	Kartasasmita A Harley O
author_sort	Kartasasmita A
title	Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
title_short	Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
title_full	Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
title_fullStr	Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
title_full_unstemmed	Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
title_sort	evaluation of the timing of intravitreal bevacizumab injection as adjuvant therapy to panretinal photocoagulation in patients with diabetic macular edema secondary to diabetic retinopathy
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/86b4e74ee0884137b2b915bf5d963f82
work_keys_str_mv	AT kartasasmitaa evaluationofthetimingofintravitrealbevacizumabinjectionasadjuvanttherapytopanretinalphotocoagulationinpatientswithdiabeticmacularedemasecondarytodiabeticretinopathy AT harleyo evaluationofthetimingofintravitrealbevacizumabinjectionasadjuvanttherapytopanretinalphotocoagulationinpatientswithdiabeticmacularedemasecondarytodiabeticretinopathy
_version_	1718401805846577152

Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy

Ejemplares similares